Which will be next money making machines in Pharma Sector

Discussion in 'Ask A Query About Your Stock Picks And Portfolio' started by kharb, Aug 18, 2015.

  1. kharb

    kharb Well-Known Member

    Joined:
    Aug 15, 2015
    Messages:
    1,023
    Likes Received:
    735
    I think Vidhi Khanna and Minakshi Razdan need to open their cards in Pharma sector on which pharma stocks they are bullish for long term.
     
  2. Srouta Mukherjee

    Srouta Mukherjee Well-Known Member

    Joined:
    Mar 28, 2015
    Messages:
    1,898
    Likes Received:
    769
    Why go running here and there? LOOK AT JB CHEM. It is yup 9.62% today. AFTER Rs. 14 dividend. STILL UNDERVALUED!!
     
  3. kharb

    kharb Well-Known Member

    Joined:
    Aug 15, 2015
    Messages:
    1,023
    Likes Received:
    735
    I have Lupin and Sun Pharma in my portfolio. But I want to invest more in Pharma sector.One option is to buy more of same Lupin and Sun Pharma .Second option is to add some other also. What is opinion of members .I want aprox 10% weightage of folio to Pharma sector and is presently under 10%.I am ready to to add one more stock.I am seeking some multibagger mid or small cap .I am a Quality stock conscious person.Which among Aarti drugs ,Suven,Granules ,Shilpa medicare ,Torrent pharma ,Alembic , Ajanta ,st acrolab,divi lab,cadila and JB chem can be biggest multibagger in long run.Pl help me to select one or maximum two of these.My long term is beyond 5 years .
     
    Last edited: Sep 14, 2015
  4. whomiiitr@gmail.com

    whomiiitr@gmail.com New Member

    Joined:
    Apr 23, 2015
    Messages:
    28
    Likes Received:
    5
    @kharb - All the stocks you mentioned are good but since you already have grown ups like Lupin and Sun Pharma, adding a small/mid cap stock with growing base would add value. I would recommend Aarti drugs, Suven, Granules, Shilpa for one reason or other.
     
  5. New_Investor

    New_Investor Active Member

    Joined:
    Sep 5, 2015
    Messages:
    528
    Likes Received:
    179
    What about SMS Pharma?
     
  6. New_Investor

    New_Investor Active Member

    Joined:
    Sep 5, 2015
    Messages:
    528
    Likes Received:
    179
    Sun Pharma, Lupin and Ajanta Pharma. Lambi race ke counter.
     
  7. Shaun Mitra

    Shaun Mitra New Member

    Joined:
    Sep 18, 2015
    Messages:
    2
    Likes Received:
    1
  8. RAMA MURTHY SASTRY CHALLA

    RAMA MURTHY SASTRY CHALLA Well-Known Member

    Joined:
    Sep 8, 2015
    Messages:
    3,688
    Likes Received:
    2,011
    Dear kharb ,
    my choice is you have already 2 big boys like Sun and Lupin ....this time go for midcap " JBCHEM" it is available in reasonable market price and business model is also good ...
    ALL THE BEST
     
    suchi likes this.
  9. Carl Icahn

    Carl Icahn Active Member

    Joined:
    Mar 25, 2015
    Messages:
    115
    Likes Received:
    92
    JB Chemicals is indeed a good stock with good management and reasonable valuations. Granules India, Indoco Remedies and Ajanta Pharma are also good mid-cap stocks to look at for a long-term portfolio.
     
  10. Sanket_jpr

    Sanket_jpr New Member

    Joined:
    Sep 18, 2015
    Messages:
    1
    Likes Received:
    0
    No one talking about wockhardt....it will be bigger than sun pharma soon.....granuels and suven and lincoln all three great to buy.....
     
  11. RAMA MURTHY SASTRY CHALLA

    RAMA MURTHY SASTRY CHALLA Well-Known Member

    Joined:
    Sep 8, 2015
    Messages:
    3,688
    Likes Received:
    2,011
    Well Said Sir....
     
    suchi likes this.
  12. Srouta Mukherjee

    Srouta Mukherjee Well-Known Member

    Joined:
    Mar 28, 2015
    Messages:
    1,898
    Likes Received:
    769
    Yes. JB Chem is a good stock. Excellent fundamentals and reasonable valuations. Ajanta Pharma is a bit expensive at present. Not sure about Indoco Remedies. Mr. Carl Icahn if you have any researh report on Indoco Remedies (latest) pl share.
     
  13. dineshkapoor27

    dineshkapoor27 Active Member

    Joined:
    May 19, 2015
    Messages:
    309
    Likes Received:
    108
    Have a look at Strides Arcolab too. Its weird no one keeps it on their radar. Shasun Pharma merger is going to be a big boon for the company. I also like Nectar life sciences and Sharon bio from purely valuations perspective (although this is a much more risky bet).
     
  14. Sumanta

    Sumanta New Member

    Joined:
    Sep 14, 2015
    Messages:
    10
    Likes Received:
    3
    Stides Arcolab, Shilpa and Suven.
     
  15. Fun_Da_Mentalist

    Fun_Da_Mentalist Active Member

    Joined:
    Sep 19, 2015
    Messages:
    240
    Likes Received:
    169
    I have been spending some time on this very question. I like Shilpa the best of the lot because they are in the Oncology space which has reasonably high barriers to entry ( translates to lower price erosion), have a strong R&D programme and have really strong financials. If I am not mistaken, close to around INR 500 reserves with total debt around INR 65 crores. They have also completed a strong investment cycle this year positioning themselves well for the next few years. The thing which is not clear to me is what % of raw materials in the production is imported.
     
    Srouta Mukherjee likes this.
  16. Fun_Da_Mentalist

    Fun_Da_Mentalist Active Member

    Joined:
    Sep 19, 2015
    Messages:
    240
    Likes Received:
    169
     
  17. Carl Icahn

    Carl Icahn Active Member

    Joined:
    Mar 25, 2015
    Messages:
    115
    Likes Received:
    92
    I think sun pharma will have to be the stock of last resort if you cannot find anything in the small or mid-cap space. When there are so many attractive mid-csp stocks like JB Chemicals, Ajanta, Shipla etc, why go with a lumbering large cap stock?
     
  18. Srouta Mukherjee

    Srouta Mukherjee Well-Known Member

    Joined:
    Mar 28, 2015
    Messages:
    1,898
    Likes Received:
    769
    Shilpa Medicare is one of favourites it has a very long growth path ahead.
     
  19. Fun_Da_Mentalist

    Fun_Da_Mentalist Active Member

    Joined:
    Sep 19, 2015
    Messages:
    240
    Likes Received:
    169
    It is useful to keep in mind that there is great value in proven track record. Also, just because a share is a " large cap" is not reason enough to bin it. As long as the profit pool it is addressing is large, it's earnings growth is climbing and it has market beating roce and roe, one should keep adding it
     
  20. Fun_Da_Mentalist

    Fun_Da_Mentalist Active Member

    Joined:
    Sep 19, 2015
    Messages:
    240
    Likes Received:
    169
    I agree. Though I must say that their revenue projections of 5 to 10 per cent is a bit of a damper to me, especially given it is trading at almost a 40 multiple. Any insights on this would be useful.
     
Loading...